{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:26:35Z","timestamp":1785587195592,"version":"3.56.0"},"reference-count":49,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.3892\/ijmm.2017.2895","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T05:57:26Z","timestamp":1487311046000},"page":"993-1000","source":"Crossref","is-referenced-by-count":42,"title":["Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-\u03baB signaling"],"prefix":"10.3892","volume":"39","author":[{"given":"Yandong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"key20180107234826_b1-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/01635581.2013.757627","article-title":"Induction of cell cycle arrest and apoptosis in human osteosarcoma U-2 OS cells by Solanum lyratum extracts","volume":"65","author":"Lin","year":"2013","journal-title":"Nutr Cancer"},{"key":"key20180107234826_b2-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/cbr.2012.1245","article-title":"Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways","volume":"27","author":"Liang","year":"2012","journal-title":"Cancer Biother Radiopharm"},{"key":"key20180107234826_b3-ijmm-39-04-0993","first-page":"1069","article-title":"Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression","volume":"40","author":"Cho","year":"2007","journal-title":"J Biochem Mol Biol"},{"key":"key20180107234826_b4-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1634\/theoncologist.9-4-422","article-title":"Biology and therapeutic advances for pediatric osteosarcoma","volume":"9","author":"Marina","year":"2004","journal-title":"Oncologist"},{"key":"key20180107234826_b5-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00148581-200810050-00005","article-title":"Therapy for osteosarcoma: where do we go from here?","volume":"10","author":"Chou","year":"2008","journal-title":"Paediatr Drugs"},{"key":"key20180107234826_b6-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1586\/14737140.6.7.1075","article-title":"Chemotherapy resistance in osteosarcoma: current challenges and future directions","volume":"6","author":"Chou","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180107234826_b7-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1158\/0008-5472.CAN-10-0090","article-title":"High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells","volume":"70","author":"Dieudonn\u00e9","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107234826_b8-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1590\/S0102-86502013000300006","article-title":"Primary tumorectomy promotes angiogenesis and pulmonary metastasis in osteosarcoma-bearing nude mice","volume":"28","author":"Wang","year":"2013","journal-title":"Acta Cir Bras"},{"key":"key20180107234826_b9-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180107234826_b10-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201043480036","article-title":"The role of ABC transporters in drug resistance, metabolism and toxicity","volume":"1","author":"Glavinas","year":"2004","journal-title":"Curr Drug Deliv"},{"key":"key20180107234826_b11-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107234826_b12-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.febslet.2006.02.020","article-title":"Mechanisms and strategies to overcome multiple drug resistance in cancer","volume":"580","author":"Ozben","year":"2006","journal-title":"FEBS Lett"},{"key":"key20180107234826_b13-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"},{"key":"key20180107234826_b14-ijmm-39-04-0993","first-page":"2461","article-title":"Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression","volume":"15","author":"Bodey","year":"1995","journal-title":"Anticancer Res"},{"key":"key20180107234826_b15-ijmm-39-04-0993","first-page":"1257","article-title":"Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells","volume":"11","author":"Chano","year":"2004","journal-title":"Oncol Rep"},{"key":"key20180107234826_b16-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ijc.21297","article-title":"Involvement of P-glycoprotein and MRP1 in resistance to cyclic tetrapeptide subfamily of histone deacetylase inhibitors in the drug-resistant osteosarcoma and Ewing's sarcoma cells","volume":"118","author":"Okada","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180107234826_b17-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"e10764","DOI":"10.1371\/journal.pone.0010764","article-title":"Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma","volume":"5","author":"Susa","year":"2010","journal-title":"PLoS One"},{"key":"key20180107234826_b18-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist Updat"},{"key":"key20180107234826_b19-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945011795378540","article-title":"Improving cancer chemotherapy with modulators of ABC drug transporters","volume":"12","author":"Shukla","year":"2011","journal-title":"Curr Drug Targets"},{"key":"key20180107234826_b20-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-2952(02)01224-8","article-title":"Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells","volume":"64","author":"Anuchapreeda","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"key20180107234826_b21-ijmm-39-04-0993","first-page":"3193","article-title":"In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line","volume":"7","author":"Cocker","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180107234826_b22-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/1535-7163.MCT-05-0018","article-title":"The selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced breast carcinoma","volume":"4","author":"Yen","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key20180107234826_b23-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2008.07.031","article-title":"Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant","volume":"131","author":"Sharma","year":"2008","journal-title":"J Control Release"},{"key":"key20180107234826_b24-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/mp050050g","article-title":"Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85","volume":"3","author":"Batrakova","year":"2006","journal-title":"Mol Pharm"},{"key":"key20180107234826_b25-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10717544.2012.674163","article-title":"PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells","volume":"19","author":"Sarisozen","year":"2012","journal-title":"Drug Delivery"},{"key":"key20180107234826_b26-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood-2009-07-229492","article-title":"P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: cancer and leukemia group B study 19808","volume":"116","author":"Kolitz","year":"2010","journal-title":"Blood"},{"key":"key20180107234826_b27-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/cncr.22492","article-title":"A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer","volume":"109","author":"Gandhi","year":"2007","journal-title":"Cancer"},{"key":"key20180107234826_b28-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/pbc.22366","article-title":"Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group","volume":"54","author":"O'Brien","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"key20180107234826_b29-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1158\/1078-0432.CCR-10-1725","article-title":"A pharmaco-dynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer","volume":"17","author":"Kelly","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107234826_b30-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1021\/np50052a001","article-title":"Bisbenzylisoquinoline alkaloids","volume":"50","author":"Schiff","year":"1987","journal-title":"J Nat Prod"},{"key":"key20180107234826_b31-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bcp.2004.01.018","article-title":"Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-delta in U937 cells","volume":"67","author":"Jang","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"key20180107234826_b32-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1158\/0008-5472.CAN-04-0313","article-title":"Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1","volume":"64","author":"Meng","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107234826_b33-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.25817","article-title":"Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma","volume":"129","author":"Liu","year":"2011","journal-title":"Int J Cancer"},{"key":"key20180107234826_b34-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bjc.2013.334","article-title":"Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)\/Akt signaling","volume":"109","author":"Wan J1 Liu","year":"2013","journal-title":"Br J Cancer"},{"key":"key20180107234826_b35-ijmm-39-04-0993","first-page":"235","article-title":"Reversal of daunorubicin resistance by tetrandrine in leukemic cells","volume":"16","author":"Ao","year":"1995","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20180107234826_b36-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00280-010-1397-7","article-title":"H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein","volume":"67","author":"Wei","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107234826_b37-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00432-009-0704-3","article-title":"Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription","volume":"136","author":"Shen","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107234826_b38-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1038\/bjc.2014.254","article-title":"Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925","volume":"110","author":"Yang","year":"2014","journal-title":"Br J Cancer"},{"key":"key20180107234826_b39-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/np400071c","article-title":"Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562\/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-\u03baB signaling inhibition","volume":"76","author":"Wang","year":"2013","journal-title":"J Nat Prod"},{"key":"key20180107234826_b40-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.toxlet.2009.11.018","article-title":"L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines","volume":"192","author":"Chiu","year":"2010","journal-title":"Toxicol Lett"},{"key":"key20180107234826_b41-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"e40720","DOI":"10.1371\/journal.pone.0040720","article-title":"Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-\u03baB in R-HepG2 cell line","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"key20180107234826_b42-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.onc.1205117","article-title":"Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling","volume":"21","author":"Kuo","year":"2002","journal-title":"Oncogene"},{"key":"key20180107234826_b43-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"key20180107234826_b44-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1087057109359422","article-title":"Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay","volume":"15","author":"Susa","year":"2010","journal-title":"J Biomol Screen"},{"key":"key20180107234826_b45-ijmm-39-04-0993","first-page":"287","article-title":"Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo","volume":"12","author":"Suto","year":"1998","journal-title":"Int J Oncol"},{"key":"key20180107234826_b46-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107234826_b47-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.3748\/wjg.v12.i26.4232","article-title":"Effect of Tetrandrine on LPS-induced NF-kappaB activation in isolated pancreatic acinar cells of rat","volume":"12","author":"Zhang","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key20180107234826_b48-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.bjp.0706000","article-title":"Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell","volume":"143","author":"Ho","year":"2004","journal-title":"Br J Pharmacol"},{"key":"key20180107234826_b49-ijmm-39-04-0993","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2017.2895\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T19:24:40Z","timestamp":1515353080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2017.2895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,17]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.3892\/ijmm.2017.2895"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2017.2895","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}